Crux Biolabs

Luminex is a multiplex assay technology that enables the simultaneous detection and quantification of many analytes in a single sample. This method reduces the time, expense, and volume of reagents needed for conventional ELISA assays while yet offering a high level of  sensitivity and specificity and allowing laboratories researchers to analyze many analytes in a single assay. 

In the fields of clinical diagnostics, life science research, and drug development, Luminex technology has a wide variety of uses.

One of the many laboratories utilizing Luminex technology is Crux Biolabs, a privately owned research facility located in Bayswater, Australia. In this blog post, we will explore Luminex Australia's perspective on Crux Biolabs, including its capabilities, achievements, and contributions to the scientific community.

Overview of Crux Biolabs: Crux Biolabs is a contract research organization (CRO) specializing in preclinical and clinical studies, in vitro diagnostics (IVD), and bioanalytical services. The lab's focus is on immunoassays, cellular assays, and molecular biology, with a team of experienced scientists using cutting-edge technology to provide high-quality data and analysis. Crux Biolabs offers a range of services, including assay development, sample analysis, and biomarker discovery, to support drug development, clinical trials, and academic research.

Luminex Technology at Crux Biolabs: Luminex technology has been an integral part of Crux Biolabs' services since its establishment. The lab uses Luminex multiplex immunoassays to measure multiple analytes in a single sample, reducing the time, cost, and volume of reagents required for traditional ELISA assays. Luminex technology has also enabled Crux Biolabs to expand its capabilities to include cell-based assays, nucleic acid detection, and protein profiling, providing a more comprehensive analysis of biological samples.

Contributions to the Scientific Community: Crux Biolabs' expertise and use of Luminex technology have resulted in several scientific publications and presentations, including studies on cancer immunotherapy, infectious diseases, and drug development. The lab has also collaborated with academic and industry partners to develop new assays and biomarkers, contributing to the advancement of medical research and diagnostics.